MedTrace Logo

CBT Group Treatment for Women With Dyspareunia

NCT03427255 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2022-04-20

No results posted yet for this study

Summary

The current study will employ a group CBT treatment program of 10 group sessions and 3 individual couple sessions targeting the thoughts, emotions, behaviors and couple interactions associated with the experience of dyspareunia. Women with superficial dyspareunia and their partners will be randomized to the CBT group program-plus or a waiting list control period at one treatment location in Sweden and two treatment locations in the Netherlands. The waiting-list control period will be comparable to the treatment duration of six months.

It is hypothesized that the group program-plus is more effective in improving pain during intercourse in women with superficial dyspareunia compared to women on a waiting-list control period.

Conditions

  • Dyspareunia

Interventions

BEHAVIORAL

CBT group treatment-plus

The CBT group program-plus consists of 3 1- hr CBT couple sessions and 10 2-hr CBT group sessions over a period of 6 months. The manualized treatment comprise, pain- and sexual education, relaxation and gradual exposure exercises as well as sensate focus and sexual communication exercises for the couple. 6-8 women participate in each group. Two psychologists conduct the couple and group sessions.

OTHER

Waiting-list control condition

Waiting-list control condition during length of active treatment (6 months).

Sponsors & Collaborators

  • Leiden University Medical Center

    collaborator OTHER

  • Maastricht University Medical Center

    collaborator OTHER

  • Örebro University, Sweden

    lead OTHER

Principal Investigators

  • Ida K Flink, PhD · Örebro University, Sweden

  • Moniek M ter Kuile, PhD · Leiden University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-29
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Netherlands
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03427255 on ClinicalTrials.gov